This may result in reduced functionality and affect the graphical presentation of this site.However, all content will still be available.
Panacur® (fenbendazole) Paste 10% is indicated for the control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early third stage (hypobiotic), late third stage and fourth stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum) and arteritis caused by hypobiotic larvae of Strongylus vulgaris in horses.
Panacur® (fenbendazole) Paste 10% has no known contraindications with any drugs1.
Panacur®ï¿½(fenbendazole) Paste 10% is administered orally at a rate of 2.3 mg/lb (5mg/kg) for the control of large strongyles, small strongyles, and pinworms. One syringe will deworm a 1,100 lb horse. For foals and weanlings (less than 18 months of age) where ascarids are a common problem, the recommended dose is 4.6 mg/lb (10 mg/kg); one syringe will deworm a 550 lb horse.
For control of encysted early third stage (hypobiotic), late third stage and fourth stage cyathostome larvae, and fourth stage larvae of Strongylus vulgaris, the recommended dose is 4.6 mg/lb (10 mg/kg) daily for 5 consecutive days; administer one syringe for each 550 lbs body weight per day.
Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.
IMPORTANT SAFETY INFORMATION: Do not use in horses intended for human consumption. When using Panacur® (fenbendazole) Paste 10% concomitantly with trichlorfon, refer to the manufacturerï¿½s labels for use and cautions for trichlorfon.
1. PANACUR® (fenbendazole) Paste 10% equine dewormer product label.
2. Lacey E. Mode of Action of Benzimidazoles. Parasitology Today, vol. 6, no. 4, 1990. 3. Based on respective product labels and FDA Freedom of Information summaries.
Copyright © 2022 Intervet Inc., a subsidiary of Merck & Co., All Rights Reserved. Intervet Inc. d/b/a Merck Animal Health, Madison, NJ 07901